|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1725 I Street NW, Suite 900 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Tamara Chrisler |
Date | 7/15/2026 5:15:54 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Federal courts and judicial nominees;
Support for confirmation of judges committed to civil and human rights;
Nomination of Katie Lane to the United States District Court for the District of Montana;
Nomination of Justin Smith to the U.S. Court of Appeals for the Eighth Circuit;
Nomination of Anthony Powell to the United States District Court for the District of Kansas;
Nomination of Anthony Mattivi to the United States District Court for the District of Kansas;
Nomination of Michael Hendershot to the United States District Court for the Northern District of Ohio;
Nomination of Benjamin Flowers to the U.S. Court of Appeals for the Sixth Circuit;
Nomination of Matthew Schwartz to the U.S. Court of Appeals for the Second Circuit;
Nomination of Daniel Traynor to the U.S. Court of Appeals for the Eighth Circuit;
Nomination of Angela Colmenero to the United States District Court for the Southern District of Texas;
Nomination of Kasdin Mitchell to the United States District Court for the Northern District of Texas;
Nomination of Daniel Domenico to the U.S. Court of Appeals for the Tenth Circuit;
Nomination of Matthew Byrne to the United States District Court for the Northern District of Ohio;
Nomination of Harold Duncan to be Deputy Director of the Office of Management and Budget.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Emily |
McDowell |
|
|
|
Ryan |
Stitzlein |
|
|
|
Samantha |
Cyrulnik-Dercher |
|
Employee in the office of Rep. Tim Walz (Minnesota) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY27 Presidents Budget;
FY27 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies, including the Hyde amendment, the Weldon amendment, funding for Title X, funding for abstinence-only education, funding for the Teen Pregnancy Prevention Program, and funding for entities that offer abortion care or training;
FY27 appropriations for Financial Services and General Government, including reproductive freedom attacks aimed at the District of Columbia, bans on abortion coverage for federal employees, and denials of coverage for contraceptive care and supplies;
FY27 appropriations for Military Construction, Veterans Affairs, and Related Agencies, including veterans access to abortion services;
FY27 appropriations for Department of Agriculture, Rural Development, Food and Drug Administration, including FDA approval of mifepristone;
FY27 appropriations for National Security, Department of State, and Related Programs, including the global gag rule, the Helms amendment, the Hyde amendment, increased funding for international family planning and reproductive health programs, increased funding for UNFPA, and the Kemp-Kasten amendment;
FY27 appropriations for Commerce, Justice, Science, and Related Agencies, including bans on abortion for people in federal prison;
FY27 appropriations for Department of Homeland Security, including access to abortion services and denials of care for people in ICE detention;
Poison pill riders in appropriations bills;
Funding for Immigration and Customs Enforcement and U.S. Customs and Border Protection;
FY27 funding for Title X family planning grants;
FY27 funding for the Teen Pregnancy Prevention Program;
FY27 funding for Division of STD prevention;
Funding cuts to Medicaid, CHIP, and other essential services that families rely on to make ends meet.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Ryan |
Stitzlein |
|
|
|
Samantha |
Cyrulnik-Dercher |
|
Employee in the office of Rep. Tim Walz (Minnesota) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
The connection between reproductive freedom and the economy;
Reproductive healthcare in FY26 and FY27 federal spending bills;
A federal right to abortion;
Federal issues related to state abortion bans and abortion access in the United States;
Administrative actions that restrict abortion access;
H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion;
Abortion-coverage restrictions;
S.4701, the Freedom to Travel for Health Care Act of 2026;
S.4922, the Reproductive Health Travel Fund Act;
H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act;
H.R.9441, the SAFE Training for OB-GYNs Act;
Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33;
Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services;
Access to evidence-based medication abortion care;
H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science;
H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act;
Veterans and their dependents access to reproductive health care;
Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act;
Anti-abortion centers/crisis pregnancy centers;
H.R.999, the Right to Contraception Act;
Access to treatments for infertility, including IVF;
H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare;
Healthy pregnancy and post-partum period;
H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color;
H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information;
Family and medical leave, including paid leave;
H.R.9261, the Comprehensive Paid Leave for Federal Employees Act;
Gender equity and sex discrimination;
H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls;
Issues related to workplace fairness and gender discrimination;
LGBTQI+ rights and discrimination against LGBTQI+ people;
Bans and restrictions on gender affirming care, including FY27 federal spending bills.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Federal Communications Commission (FCC), Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Ryan |
Stitzlein |
|
|
|
Samantha |
Cyrulnik-Dercher |
|
Employee in the office of Rep. Tim Walz (Minnesota) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
The link between immigrant justice and reproductive reproductive freedom;
H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Samantha |
Cyrulnik-Dercher |
|
Employee in the office of Rep. Tim Walz (Minnesota) |
|
Emily |
Steinert McDowell |
|
|
|
Ryan |
Stitzlein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
The intersection of reproductive freedom, democracy, and voting rights;
H.Res.1384, expressing the sense of the House of Representatives that Congress must urgently take all appropriate measures to guarantee civil rights and fair political representation to all Americans;
H.R.7296 and S. 1383, and H.R.22, the Safeguard American Voter Eligibility (SAVE) Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Emily |
Steinert McDowell |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Funding for international family planning programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |